New gene therapy trial aims to control hepatitis b virus
Disease control
Recruiting now
This early-stage study is testing a new gene therapy called CRMA-1001 in adults with chronic hepatitis B. The main goal is to see if the treatment is safe and how the body handles it. Researchers will also check if it helps control the hepatitis B virus and might allow some peopl…
Phase: PHASE1, PHASE2 • Sponsor: nChroma Bio • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC